Search results
One of AbbVie's post-Humira hopefuls gets closer to clearing hurdle in Europe
Crain s Chicago Business· 7 days agoAbbVie has received good news from the European Medicines Agency for a new use of its anti-inflammation drug Skyrizi, one of the best-selling products in its portfolio, now ...
CERE (NASDAQ) REMINDER: BFA Law Reminds Cerevel Shareholders to Inquire About Ongoing Investigation...
Benzinga· 6 days agoNEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) and AbbVie, Inc. If you invested in
Medtronic plc (NYSE:MDT): The Best Healthcare Dividend Aristocrat Stock To Buy?
Insider Monkey via Yahoo Finance· 18 hours agoWe recently compiled the list of 25 Best Dividend Aristocrats Stocks According to Analysts. Since...
Exploring Three Growth Companies With High Insider Ownership On Euronext Paris
Simply Wall St. via Yahoo Finance· 7 hours agoAmidst a backdrop of fluctuating European markets, with France's CAC 40 Index recently experiencing...
Top Stocks to Buy in June
Motley Fool via Yahoo Finance· 3 days agoIn today's video, I will look into a few dividend stocks and one growth stock that look intriguing at current valuations. One of those stocks includes a...
AbbVie Hit With Investor Lawsuit Over Director Removal Bylaw
Bloomberg Law· 4 days agois the latest company facing a legal challenge to a bylaw that gives its board the power to oust individual members over errors, omissions, or lies in their paperwork. The proposed class action ...
Once-Weekly Somapacitan Remains Safe, Effective Long-Term
Medscape· 8 hours agoGrowth improvements were similar between children taking somapacitan for 3 years and those who...
3 Dividend Stocks You May Want To Double Down On
Benzinga via Yahoo Finance· 3 days agoSometimes, misunderstood stocks benefit investors. Savvy investors can capitalize when a stock is incorrectly perceived as weak during a recession....
Lilly details MASH data for tirzepatide; Cytokinetics comments on past sale talks
BioPharma Dive via Yahoo Finance· 2 days agoA study abstract shed more light on tirzepatide’s potential in MASH. Elsewhere, Cytokinetics CEO...
Bulevirtide/Pegylated Interferon Combo Beats Monotherapy for Chronic Hepatitis D
MedPage Today· 1 day agoAt 24 weeks after the end of treatment, HDV RNA levels were undetectable in 46% of patients who...